Profound Medical Corp.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-3.98 | -268.1 | -98.52% | -9.42 | -57.79% |
| P/S |
|
16.35 | 55.96 | -70.78% |
|
|
| P/BV |
|
2.89 | 251.23 | -98.85% |
|
|
| P/FCF |
|
-4.49 | -193.71 | -97.68% |
|
|
| Ev/Ebitda |
|
-3.77 | 12.23 | -130.86% |
|
|
| Ev/S |
|
11.69 | 457.86 | -97.45% |
|
|
| Ev/FCF |
|
-5.32 | -232.19 | -97.71% |
|
|
| E/P |
|
-0.2515 | 0.0158 | -1686.98% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-309.57 | -339.51 | -8.82% | -384.59 | -19.51% |
| ROE |
|
-57.84 | 98.24 | -158.88% |
|
|
| ROA |
|
-46.38 | -5.02 | 823.48% |
|
|
| ROIC |
|
0 | 1.2 | -100% |
|
|
| ROS |
|
-247.94 | -298.06 | -16.82% |
|
|
| ROCE |
|
-48.19 | -0.0718 | 67039.35% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1549 | 0.9431 | -116.42% | -0.1779 | -12.95% |
| Nеt Debt/Ebitda |
|
1.51 | 1.03 | 46.9% |
|
|
| Debt/Ratio |
|
0.0729 | 0.1785 | -59.16% |
|
|
| Debt/Equity |
|
0.1624 | 1.56 | -89.59% |
|
|
| Debt/Net Income |
|
-0.1934 | -1.48 | -86.93% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5195 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8478 | -100% | ||
| DSI |
|
0 | 0.2116 | -100% |
|
|
| Average dividend growth |
|
0 | 1.31 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4975 | -100% |
|
|
| Average percentage for payments |
|
0 | 58.24 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5195 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
6/10
|
46.3 | -87.95 | -152.64% | ||
| Growth impulse Ebitda in 5 years |
|
99.17 | -156.19 | -163.49% | ||
| Growth impulse Net Income in 5 years |
|
22.59 | -172.49 | -113.1% | ||
| Growth impulse FCF in 5 years |
|
12.22 | -114.63 | -110.66% | ||
| Growth impulse EPS in 5 years |
|
-14.46 | -121.56 | -88.1% |
IP Score
3.6/10
